ArticleDrug design, development and therapy2022

Predicting Outcome in Combination Treatment of TACE and Camrelizumab for Advanced Hepatocellular carcinoma: Tumor Hypervascularity and Reactive Cutaneous Capillary Endothelial Proliferation.

Liang Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.